Larimar Therapeutics Inc (LRMR)

SG&A Expense Growth

4.35%

Quarterly · Period ending:

LRMR logo

LRMR SG&A Expense Growth

Latest reported4.35%
LRMR Quarterly SG&A Growth (QoQ) (0.00% → 4.35%)
High-resolution chart · PNG

LRMR sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Larimar Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
4.3543%
31.0226%
-0.4927%
5.5154%
-4.5729%
1.7783%
4.8331%
-11.6331%
29.5652%
7.9966%
-6.3932%
0.2403%
21.7886%
-4.5328%
9.8942%
-3.6806%
-1.2334%
10.272%
3.4049%
-21.4763%
9.8659%
-18.0534%
11.8852%
37.0787%
49.4901%
121.6755%
26.5993%
3.125%
114,641.0359%
-99.9845%
-3.1447%
-0.3581%
2.5084%
33.5922%
-21.495%
3.6237%
-16.165%
12.125%
-33.7474%
-1.4085%
-8.6007%
-3.2491%
-0.1082%
9.0873%
68.0661%
0%
0%
76.9946%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.